Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
dc.contributor.author | James, S | |
dc.contributor.author | Erlinge, D | |
dc.contributor.author | Storey, RF | |
dc.contributor.author | McGuire, DK | |
dc.contributor.author | de Belder, M | |
dc.contributor.author | Eriksson, N | |
dc.contributor.author | Andersen, K | |
dc.contributor.author | Austin, D | |
dc.contributor.author | Arefalk, G | |
dc.contributor.author | Carrick, D | |
dc.contributor.author | Hofmann, R | |
dc.contributor.author | Hoole, SP | |
dc.contributor.author | Jones, DA | |
dc.contributor.author | Lee, K | |
dc.contributor.author | Tygesen, H | |
dc.contributor.author | Johansson, PA | |
dc.contributor.author | Langkilde, AM | |
dc.contributor.author | Ridderstråle, W | |
dc.contributor.author | Parvaresh Rizi, E | |
dc.contributor.author | Deanfield, J | |
dc.contributor.author | Oldgren, J | |
dc.date.accessioned | 2023-11-17T12:57:27Z | |
dc.date.available | 2023-11-17T12:57:27Z | |
dc.identifier.issn | 2766-5526 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/92044 | |
dc.publisher | Massachusetts Medical Society | en_US |
dc.relation.ispartof | NEJM Evidence | |
dc.title | Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1056/evidoa2300286 | |
pubs.notes | Not known | en_US |